amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil · Cosette · NDA 200175
Tribenzor
Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 200175-00124 Nov 2025
- 25 Oct 2026Generic approved · 200175-0016 Oct 2025
Products covered · 5
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 200175 · 001 · RLD | tablet, oral | EQ 5MG BASE;12.5MG;20MG | open |
| 200175 · 002 · RLD | tablet, oral | EQ 5MG BASE;12.5MG;40MG | open |
| 200175 · 003 · RLD | tablet, oral | EQ 5MG BASE;25MG;40MG | open |
| 200175 · 004 · RLD | tablet, oral | EQ 10MG BASE;12.5MG;40MG | open |
| 200175 · 005 · RLD | tablet, oral | EQ 10MG BASE;25MG;40MG | open |